![Picture of Lisa Gieg](/sites/default/files/styles/medium/public/gieg_photo.jpg?itok=Nqikf2ZU)
Showing 21 - 30 of 36 results
University of Calgary
Petroleum microbiology related to hydrocarbon biodegradation, bioremediation, enhanced oil recovery, biocorrosion, oil sands tailings pond microbiology, and identifying and characterizing microbial communities and their functions in diverse environments
University Health Network
Offers cell processing and manufacturing services to support innovative anti-cancer cell therapies and blood and marrow transplantation.
Image
![Princess Margaret Genomics Centre](/sites/default/files/styles/large/public/logo/pmgclogo_lightbox.jpg?itok=IFLSGhJm)
University Health Network
Genomics, epigenomics and functional genomics services and technology development. Specializing in clinically relevant samples and single cell genomics analysis, and spatial transcriptomics analysis.
Image
![Dalhousie University](/sites/default/files/styles/large/public/logo/dal-fullmark-gd_onscreen_5.jpg?itok=ad4Cm1Sb)
Dalhousie University
Mass spectrometry-based analytical laboratory providing proteomic, metabolomic and lipidomic services in medical and biological sciences
The Hospital for Sick Children
Functional neuroimaging
Image
![Structural and Biophysiocal Core Facility](/sites/default/files/styles/large/public/2021-06/sbcfacility_logo_jpg-resized.jpg?itok=zFU1toRj)
The Hospital for Sick Children
Instrument facility specializing in biophysical characterization methods used for investigating biomolecular structure, stability, interactions, dynamics and enzymology.
The Hospital for Sick Children
Genomics and molecular biology research and service provision
University Health Network
Designs, develops and tests new assistive technologies and treatments to enhance the lives of older people and those with disabling injuries or illness
Image
![UHN Princess Margaret Living Biobank](/sites/default/files/styles/large/public/2022-04/Logo.png?itok=SS3tGUWR)
University Health Network
Support resources and services for the use of annotated patient-derived (PD) models including xenografts (PDX) and organoids (PDO) models for research that make an impact in precision cancer medicine.